Citing the increased risk of suicidal thoughts and behavior in some children and adolescents who use antidepressants, the U.S. Food and Drug Administration issued a public-health advisory Oct. 15 saying a warning label would be added to such medications. The “black box” warning, the most serious of those placed on prescription-drug labels, will emphasize the need to monitor young patients who take the drugs.